| LP164944-3 | Loperamide induced platelet IgG | COMPONENT | 1 |
| LP164945-0 | Loperamide induced platelet IgM | COMPONENT | 1 |
| LP164947-6 | Loratadine induced neutrophil Ab | COMPONENT | |
| LP164948-4 | Loratadine induced neutrophil IgG | COMPONENT | 1 |
| LP164949-2 | Loratadine induced neutrophil IgM | COMPONENT | 1 |
| LP16495-1 | HLA-A19 | COMPONENT | 2 |
| LP164951-8 | Loratadine induced platelet Ab | COMPONENT | |
| LP164952-6 | Loratadine induced platelet IgG | COMPONENT | 1 |
| LP164953-4 | Loratadine induced platelet IgM | COMPONENT | 1 |
| LP164955-9 | LORazepam induced platelet Ab | COMPONENT | |
| LP164956-7 | LORazepam induced platelet IgG | COMPONENT | 1 |
| LP164957-5 | LORazepam induced platelet IgM | COMPONENT | 1 |
| LP164959-1 | Losartan induced neutrophil Ab | COMPONENT | |
| LP16496-9 | HLA-A33(19) | COMPONENT | 2 |
| LP164960-9 | Losartan induced neutrophil IgG | COMPONENT | 1 |
| LP164961-7 | Losartan induced neutrophil IgM | COMPONENT | 1 |
| LP164963-3 | Losartan induced platelet Ab | COMPONENT | |
| LP164964-1 | Losartan induced platelet IgG | COMPONENT | 1 |
| LP164965-8 | Losartan induced platelet IgM | COMPONENT | 1 |
| LP164967-4 | Lovastatin induced platelet Ab | COMPONENT | |
| LP164968-2 | Lovastatin induced platelet IgG | COMPONENT | 1 |
| LP164969-0 | Lovastatin induced platelet IgM | COMPONENT | 1 |
| LP16497-7 | HLA-A34(10) | COMPONENT | 2 |
| LP164971-6 | Meropenem induced platelet Ab | COMPONENT | |
| LP164972-4 | Meropenem induced platelet IgG | COMPONENT | 1 |
| LP164973-2 | Meropenem induced platelet IgM | COMPONENT | 1 |
| LP164975-7 | metFORMIN induced neutrophil Ab | COMPONENT | |
| LP164976-5 | metFORMIN induced neutrophil IgG | COMPONENT | 1 |
| LP164977-3 | metFORMIN induced neutrophil IgM | COMPONENT | 1 |
| LP164979-9 | metFORMIN induced platelet Ab | COMPONENT | |
| LP16498-5 | Bacampicillin | COMPONENT | 6 |
| LP164980-7 | metFORMIN induced platelet IgG | COMPONENT | 1 |
| LP164981-5 | metFORMIN induced platelet IgM | COMPONENT | 1 |
| LP164983-1 | Methocarbamol induced platelet Ab | COMPONENT | |
| LP164984-9 | Methocarbamol induced platelet IgG | COMPONENT | 1 |
| LP164985-6 | Methocarbamol induced platelet IgM | COMPONENT | 1 |
| LP164987-2 | Methotrexate induced platelet Ab | COMPONENT | |
| LP164988-0 | Methotrexate induced platelet IgG | COMPONENT | 1 |
| LP164989-8 | Methotrexate induced platelet IgM | COMPONENT | 1 |
| LP16499-3 | HLA-A36 | COMPONENT | 2 |
| LP164991-4 | Methyldopa induced platelet Ab | COMPONENT | |
| LP164992-2 | Methyldopa induced platelet IgG | COMPONENT | 1 |
| LP164993-0 | Methyldopa induced platelet IgM | COMPONENT | 1 |
| LP164995-5 | Methylphenidate induced neutrophil Ab | COMPONENT | |
| LP164996-3 | Methylphenidate induced neutrophil IgG | COMPONENT | 1 |
| LP164997-1 | Methylphenidate induced neutrophil IgM | COMPONENT | 1 |
| LP164999-7 | Methylphenidate induced platelet Ab | COMPONENT | |
| LP16500-8 | HLA-A43 | COMPONENT | 2 |
| LP165000-3 | Methylphenidate induced platelet IgG | COMPONENT | 1 |
| LP165001-1 | Methylphenidate induced platelet IgM | COMPONENT | 1 |